Plavix misses Phase III endpoint

Plavix clopidogrel from sanofi-aventis (Euronext:SAN; SNY) and Bristol-Myers (BMY) missed the primary endpoint, which was a composite of myocardial infarction (MI), stroke or death from cardiovascular...